Trump Expected to Fire FDA Head Amid Agency Turbulence

Marty Makary is reported to be the latest high-profile health official facing termination, as political dynamics shift within the Trump administration. His departure continues a trend of leadership changes affecting key health agencies. This could impact the Food and Drug Administration (FDA) as it navigates ongoing public health challenges. Market reactions to such changes in leadership at the FDA can lead to volatility in healthcare stocks.